Evidence map›Paper›PMID 27899607›Full record

ArticleNucleic acids research2017

The adenovirus L4-22K protein regulates transcription and RNA splicing via a sequence-specific single-stranded RNA binding.

Susan Lan, Wael Kamel, Tanel Punga, Göran Akusjärvi

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Susan LanDepartment of Medical Biochemistry and Microbiology, Uppsala Biomedical Center, Uppsala University, S-751 23 Uppsala, Sweden.
Wael KamelDepartment of Medical Biochemistry and Microbiology, Uppsala Biomedical Center, Uppsala University, S-751 23 Uppsala, Sweden.
Tanel PungaDepartment of Medical Biochemistry and Microbiology, Uppsala Biomedical Center, Uppsala University, S-751 23 Uppsala, Sweden.
Göran AkusjärviDepartment of Medical Biochemistry and Microbiology, Uppsala Biomedical Center, Uppsala University, S-751 23 Uppsala, Sweden.
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adenovirus L4-22K protein both activates and suppresses transcription from the adenovirus major late promoter (MLP) by binding to DNA elements located downstream of the MLP transcriptional start site: the so-called DE element (positive) and the R1 region (negative). Here we show that L4-22K preferentially binds to the RNA form of the R1 region, both to the double-stranded RNA and the single-stranded RNA of the same polarity as the nascent MLP transcript. Further, L4-22K binds to a 5΄-CAAA-3΄ motif in the single-stranded RNA, which is identical to the sequence motif characterized for L4-22K DNA binding. L4-22K binding to single-stranded RNA results in an enhancement of U1 snRNA recruitment to the major late first leader 5΄ splice site. This increase in U1 snRNA binding results in a suppression of MLP transcription and a concurrent stimulation of major late first intron splicing.

Indexed as

Gene Expression RegulationRNA SplicingTranscription, GeneticAdenoviruses, HumanBase SequenceBinding SitesDNA, Single-StrandedGene Expression Regulation, ViralGene OrderHumansIntronsModels, BiologicalNucleotide MotifsProtein BindingRibonucleoprotein, U1 Small NuclearRNA-Binding ProteinsDNA, Single-StrandedL4-22K protein, adenovirusRibonucleoprotein, U1 Small NuclearRNA-Binding ProteinsRNA Splice SitesViral Nonstructural Proteins

Identifiers

PMID27899607
PMCPMC5389519
OpenAlexW2557926812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.